Emil Hartela Investing
Subscribe
Sign in
Home
Archive
Leaderboard
About
Latest
Top
Discussions
Execution Memo No. 10 (Tempus update)
TechBio Carnage: Not the Time to Panic, Time to Capitalize
Nov 7
•
Emil
1
Haypp Group Q3 (Long Update)
Feeling Bullish. 2026 is Haypp’s Year.
Nov 7
•
Emil
3
Execution Memo No. 9
Haypp, Tempus, and TPB face their moment of truth
Nov 6
•
Emil
1
October 2025
Haypp Group Q3 Earnings Preview
Weak summer months aside, all signals point to record volumes
Oct 31
•
Emil
3
Execution Memo No. 8
A rapid-fire portfolio rundown and the next moves in motion.
Oct 24
•
Emil
HAYPP Watch: September 2025 & Q3
Haypp looks set for its best quarter ever; I’ll share my Q3 forecast in this report.
Oct 9
•
Emil
2
Execution Memo No. 007
Turning Point Brands: From Vision to Results
Oct 7
•
Emil
1
Execution Memo No. 006
Position updates, portfolio shifts, and a 45% gain in under 24 hours
Oct 2
•
Emil
1
September 2025
Execution Memo No. 005
123% YTD; Extreme Volatility; Biotech Takes the Lead 24.09.2025
Sep 24
•
Emil
1
Tempus AI: deep dive
A giant in the making
Sep 22
•
Emil
8
1
Execution Memo No. 004
Shifting From AI Infra to Biotech
Sep 19
•
Emil
1
Is Lyft About to Become the Biggest AV Winner?
Wall Street wrote off Lyft as a dying value stock; autonomous vehicles could turn it into a growth story overnight.
Sep 17
•
Emil
1
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
